Fleurus, Belgium

Ire-Celltarg S.a.


USPTO Granted Patents = 10

Forward Citations = 260

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Andre B Trouet (4 out of 12 patents)

silverMedal Philippe Pirson (2 out of 2 patents)

bronzeMedal Jean-Bernard Falmagne (2 out of 2 patents)

4.  Marie-Paule Collard (2 out of 2 patents)

5.  Marc Zeicher (2 out of 2 patents)

6.  Jacques Quivy (2 out of 2 patents)

7.  Jean-Paul Dejonghe (2 out of 4 patents)

8.  Brigitte Evrard (1 out of 7 patents)

9.  Alex Bollen (1 out of 14 patents)

10.  Philippe Teyssie (1 out of 30 patents)

11.  Robert Jerome (1 out of 18 patents)

12.  Roger Baurain (1 out of 1 patent)

13.  Jose Bontemps (1 out of 1 patent)

14.  Luc Delattre (1 out of 1 patent)

15.  Ksp Siva Rao (1 out of 1 patent)


10 patents:

Company Overview
Ire-Celltarg S.a. is a biotechnology company based in Fleurus, Belgium, specializing in the development of innovative therapeutic solutions. The organization focuses on advanced cell and gene therapies, aiming to address unmet medical needs in various disease areas. With a commitment to research and development, Ire-Celltarg leverages cutting-edge technologies to enhance treatment efficacy and patient outcomes, positioning itself as a key player in the evolving landscape of biopharmaceuticals.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#1 in Fleurus

#255 in Belgium

#56,047 in the World

Fleurus, BE
Fleurus, Belgium
Forward Citations = 260

25 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ire-Celltarg S.a.. Retrieved from https://idiyas.com/company/ire-celltarg-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…